Showing 1 - 6 results of 6 for search 'Claudia Palladino', query time: 0.04s Refine Results
  1. 1
    Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

    Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique. by Claudia Palladino, Verónica Briz, José María Bellón, Inês Bártolo, Patrícia Carvalho, Ricardo Camacho, M Ángeles Muñoz-Fernández, Rui Bastos, Rolanda Manuel, José Casanovas, Nuno Taveira

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots.

    Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots. by Francisco Martin, Claudia Palladino, Rita Mateus, Anna Bolzan, Perpétua Gomes, José Brito, Ana Patrícia Carvalho, Yolanda Cardoso, Cristovão Domingos, Vanda Sofia Lôa Clemente, Nuno Taveira

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals

    Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Indivi... by Francisco Martin, José Maria Marcelino, Claudia Palladino, Inês Bártolo, Susana Tracana, Inês Moranguinho, Paloma Gonçalves, Rita Mateus, Rita Calado, Pedro Borrego, Thomas Leitner, Sofia Clemente, Nuno Taveira

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012.

    Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012. by Claudia Palladino, Verónica Briz, José María Bellón, Francisco J Climent, Santiago J de Ory, María José Mellado, María Luisa Navarro, José T Ramos, Nuno Taveira, María Isabel de José, María Ángeles Muñoz-Fernández, CoRISpeS-Madrid Cohort Working Group

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

    Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance by Paula Martínez-Román, Celia Crespo-Bermejo, Daniel Valle-Millares, Violeta Lara-Aguilar, Sonia Arca-Lafuente, Luz Martín-Carbonero, Pablo Ryan, Ignacio de los Santos, María Rosa López-Huertas, Claudia Palladino, María Muñoz-Muñoz, Amanda Fernández-Rodríguez, Mayte Coiras, Verónica Briz, on behalf of the COVIHEP network

    Published 2022-06-01
    Get full text
    Article
  6. 6
    Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients

    Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients by Daniel Valle-Millares, Óscar Brochado-Kith, Luz Martín-Carbonero, Lourdes Domínguez-Domínguez, Pablo Ryan, Ignacio De los Santos, Sara De la Fuente, Juan M. Castro, María Lagarde, Guillermo Cuevas, Mario Mayoral-Muñoz, Mariano Matarranz, Victorino Díez, Alicia Gómez-Sanz, Paula Martínez-Román, Celia Crespo-Bermejo, Claudia Palladino, María Muñoz-Muñoz, María A. Jiménez-Sousa, Salvador Resino, Verónica Briz, Amanda Fernández-Rodríguez, on Behalf of Multidisciplinary Group of Viral Coinfection HIV/Hepatitis (COVIHEP)

    Published 2021-11-01
    Get full text
    Article

Search Tools: